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Renal magnesium is mainly reabsorbed by a paracellular pathway in the thick ascending limb of Henle. The expression of claudin-16 increased
magnesium transport in Madin–Darby canine kidney (MDCK) cells. Little is known about the regulatory mechanism of magnesium transport via
claudin-16. Here we examined the effect of a polyvalent cation-sensing receptor (CaSR) on the intracellular distribution of and transport of
magnesium by claudin-16. FLAG-tagged claudin-16 was stably expressed in MDCK cells using a Tet-OFF system. The activation of CaSR by
magnesium, calcium, neomycin, and gadolinium did not affect the expression of FLAG-tagged claudin-16, CaSR, or ZO-1, a tight junctional
scaffolding protein. These activators decreased the phosphoserine level of FLAG-tagged claudin-16 and the association of FLAG-tagged claudin-
16 with ZO-1. The activation of CaSR induced a decrease in PKA activity. Immunofluorescence microscopy revealed that FLAG-tagged claudin-
16 is distributed at the cell–cell border under unstimulated conditions, whereas it translocates to the intracellular compartment, mainly lysosome,
with the activation of CaSR. In contrast, the distribution of ZO-1 was unaffected by the activation. The expression of FLAG-tagged claudin-16
increased transepithelial electrical resistance (TER) and transepithelial magnesium transport without affecting FITC-dextran (MW 4000) flux. The
activation of CaSR decreased TER and magnesium transport, which were recovered by co-treatment with dibutyryl cAMP, a membrane-permeable
cAMP analogue. Taken together, CaSR activation may decrease PKA activity, resulting in a decrease in phosphorylated claudin-16, the
translocation of claudin-16 to lysosome and a decrease in magnesium reabsorption.
© 2007 Elsevier B.V. All rights reserved.Keywords: Claudin-16; PKA; Phosphorylation; Polyvalent cation-sensing receptor1. Introduction
Serum magnesium levels are kept within a narrow range.
Magnesium homeostasis is controlled by the balance between
intestinal absorption and renal excretion. Under physiological
conditions, a decrease in magnesium intake is supplemented by
enhanced magnesium absorption in the intestine and reduced
excretion in the kidney. Renal magnesium filtered in theAbbreviations: CaSR, polyvalent cation-sensing receptor; MDCK, Madin–
Darby canine kidney; PKA, protein kinase A; TAL, thick ascending limb; TER,
transepithelial electrical resistance
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doi:10.1016/j.bbamem.2007.10.002glomeruli is mainly reabsorbed in the thick ascending limb
(TAL) of Henle [1]. In this segment, magnesium is passively
transported from the lumen to the interstitial space through the
paracellular pathway, driven by the lumen-positive transepithe-
lial voltage [2,3].
A primary barrier to the passage of solutes through the
paracellular space is formed by the tight junction (TJ) complex.
The permeability to ions via the paracellular pathway may be
controlled by tight junctional proteins [4]. The TJ complex is
composed of various membrane integral proteins, scaffolding
proteins, and cytoskeletal proteins. The membrane integral
proteins include occludin, a 65 kDa protein bearing four
transmembrane domains [5], and claudins, 20–28 kDa proteins
that share a common topology with occludin [6]. Claudins
Fig. 2. Decrease of phosphorylated CLDN-16 by CaSR agonists. The cells express
MgCl2 (5 and 10 mM), CaCl2 (5 and 10 mM), neomycin (0.1 and 0.5 mM), and Gd
PAGE, followed by immunoblotting with anti-FLAG, anti-ZO-1, anti-CaSR, or anti-a
anti-FLAG antibody. Then, the immune pellets were immunoblotted with anti-phos
Fig. 1. Inducible expression of FLAG-tagged CLDN-16 in the MDCK Tet-OFF
cells. Cells were cultured in the presence (+) or absence (−) of 100 ng/ml
doxycycline. The cell lysates were separated by SDS-PAGE, followed by
immunoblotting with anti-FLAG, anti-ZO-1, anti-CaSR or anti-actin antibody.
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several essential features [7,8]. The carboxyl terminus of most
claudins has a PDZ-binding motif that can interact with the PDZ
domains of scaffolding proteins ZO-1, ZO-2, and ZO-3 [9,10].
Different claudins can exist within the same junction where they
interact in a homophilic or heterophilic manner [11–13]. By
changing the combination of claudins in each tissue, one may
show the variation in paracellular permeability.
Claudin-16 (CLDN-16) is exclusively expressed in the TAL
where most of the magnesium is reabsorbed. Using a positional
cloning approach, Simon et al. [14] found mutations in the
CLDN-16 gene in cases of familial hypomagnesemia with
hypercalciuria and nephrocalcinosis. Therefore, CLDN-16
seems to function as a paracellular magnesium transport path-
way. At present, little is known about the regulatory mechanism
of the expression and intracellular distribution of CLDN-16.
Numerous mutants of CLDN-16, which are identified in
FHHNC, induce a mistargeting of CLDN-16 to the TJ [15,16].
We recently reported that phosphorylation by a cAMP/PKA-
dependent pathway is necessary for CLDN-16 to distribute to theing the FLAG-tagged CLDN-16 were incubated with CaSR agonists including
Cl3 (0.1 and 0.5 mM) for 1.5 h. (A) The total cell lysate was separated by SDS-
ctin antibody. (B) The total cell lysates were immunoprecipitated with polyclonal
phoserine (P-Ser), anti-ZO-1, or monoclonal anti-FLAG antibody.
Fig. 3. Effects of CaSR agonists on PKA activity. The cells expressing the
FLAG-tagged CLDN-16 were incubated with CaSR agonists including MgCl2
(5 and 10 mM), CaCl2 (5 and 10 mM), neomycin (0.1 and 0.5 mM), and GdCl3
(0.1 and 0.5 mM) for 1.5 h. Then the cells were lysed in Omnia Cell Extraction
Buffer. The PKA activity was represented as relative fluorescence intensity.
⁎⁎Pb0.01, compared with control.
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tion of CLDN-16 into the TJ would be a key regulatory step.
A calcium-sensing receptor (CaSR) is expressed in the renal
tubules and senses changes in extracellular calcium and
magnesium levels [18]. In cases of familial hypocalciuric hyper-
calcemia (FHH), an inherited disorder with mutations in the
CaSR gene, individuals exhibit low urinary calcium excretion
even if their plasma calcium concentration is high [19]. Hebert
et al. [20] proposed that the elevation of plasma calcium and
magnesium concentrations induces the activation of CaSR
followed by a reduction in the reabsorption of NaCl in the TAL.
This in turn decreases the lumen-positive potential that is the
driving force for calcium and magnesium transport. However, it
is unknown whether the activation of CaSR directly affects the
expression and function of CLDN-16.
In the present study, we investigated the effect of CaSR
agonists on the intracellular distribution of and transport of
magnesium by CLDN-16 using Madin–Darby canine kidney
(MDCK) Tet-OFF cells. We found that the agonists decrease the
level of phosphorylated CLDN-16 and induce the translocation
of CLDN-16 from the TJ to intracellular compartments, in
particular to lysosome. The transepithelial transport of magne-
sium from the apical-to-basal compartments was decreased by
the agonists. We suggest that the activation of CaSR decreases
the distribution of CLDN-16 in the TJ and is partially involved
in the down-regulation of magnesium reabsorption in the TAL.
2. Materials and methods
2.1. Materials
Monoclonal mouse anti-FLAG and monoclonal anti-phosphoserine anti-
bodies were obtained from Sigma-Aldrich (Saint Louis, MO, USA). Polyclonal
rabbit anti-FLAG was from Medical & Biological Laboratories (Aichi, Japan).
Polyclonal goat anti-actin and polyclonal rabbit anti-ZO-1 antibodies, and
ExactaCruz C were from Santa Cruz Biotechnology (Santa Cruz, CA, USA). All
other reagents were of the highest grade of purity available.
2.2. Cell culture and transfection
The MDCK (type II) Tet-OFF cell line was obtained from BD Biosciences
Clontech (Franklin Lakes, NJ, USA). FLAG-tagged CLDN-16 was stably
expressed in the MDCK Tet-OFF cells [21]. Cells were grown in Dulbecco's
modified Eagle's medium (Sigma-Aldrich) supplemented with 5% fetal calf
serum (HyClone, Logan, UT, USA), 0.07 mg/ml penicillin-G potassium,
0.14 mg/ml streptomycin sulfate, 0.1 mg/ml G418, and 0.1 mg/ml hygromycin
B in a 5% CO2 atmosphere at 37 °C. The expression of FLAG-tagged CLDN-16
was induced by adding 0.1 μg/ml doxycycline.
2.3. Preparation of membrane fraction and immunoprecipitation
Confluent MDCK cells were scraped into cold PBS and precipitated by
centrifugation. Then, the cells were lysed in a RIPA buffer containing 150 mM
NaCl, 0.5 mM EDTA, 1% Triton X-100, 0.1% sodium dodecyl sulfate, 50 mM
Tris–HCl (pH 8.0), a protease inhibitor cocktail (Sigma-Aldrich), 1 mM
phenylmethylsulfonyl fluoride, and 1 mM sodium orthovanadate, and sonicated
for 20 s. After centrifugation at 6000 ×g for 5 min, the supernatant was collected
(total cell lysate). The total cell lysate (500 μg) was incubated with polyclonal
anti-FLAG antibody and ExactaCruz B for 12–16 h at 4 °C with gentle rocking.
After centrifugation at 5000 ×g for 1 min, the pellet was washed three times with
the RIPA buffer. The total cell lysate and immunoprecipitate were solubilized in
a sample buffer for SDS-polyacrylamide gel electrophoresis. Protein concentra-tions were measured using a protein assay kit (Bio-Rad Laboratories, Hercules,
CA, USA) with bovine serum albumin as the standard.
2.4. SDS-polyacrylamide gel electrophoresis and immunoblotting
SDS-polyacrylamide gel electrophoresis was carried out as described
previously [22]. In brief, the total cell lysate (30 μg) or immunoprecipitate was
applied to the SDS-polyacrylamide gel. Proteins were blotted onto a PVDF
membrane and incubatedwith each primary antibody for 16 h at 4 °C followed by
a peroxidase-conjugated secondary antibody for 1 h at room temperature. Finally,
the blots were stained with an ECLWestern blotting kit from GE Healthcare UK
Ltd. (Amersham Place, England).
2.5. Confocal microscopy
MDCK cells expressing the FLAG-tagged CLDN-16 were plated at a
confluent density on cover glasses and, if necessary, were preincubated with
lysotracker for 30 min at 37 °C. Immunofluorescence microscopywas performed
as described previously [23]. Immunolabeled cells were visualized on an LSM
510 confocal microscope (Carl Zeiss, Germany) set with a filter appropriate for
Texas Red (543 nm excitation, 585–615 nm emission), and FITC (488 nm
excitation, 530 nm emission). Images were further processed using Adobe
Photoshop (Adobe System, San Jose, CA, USA).
2.6. Measurement of PKA activity
PKA activity was assessed using a Kinase Activity Assay Kit for PKA
(BioSource, Nivelles, Belgium). MDCK cells expressing the FLAG-tagged
CLDN-16 were lysed in Omnia Cell Extraction Buffer. After centrifugation at
16,000 ×g for 30 min, the supernatant was used for the assay. PKA activity was
determined following the manufacturer's instructions. The fluorescence intensity
was measured with excitation at 360 nm and emission at 485 nm using a
Multilabel Counter 1420 ARVOsx (Perkin Elmer, Wellesley, MA, USA). Data
were represented as relative fluorescence intensity.
2.7. Measurement of paracellular permeability
MDCK cells expressing the FLAG-tagged CLDN-16 were plated at a
confluent density on Transwells with polyester membrane inserts (6.5 or 12 mm
Fig. 5. Translocation of CLDN-16 to lysosome by CaSR agonists. The cells
expressing the FLAG-tagged CLDN-16 were cultured in the presence or
absence of CaSR agonists including 5 mM CaCl2, 5 mM MgCl2, 0.5 mM
neomycin, and 0.5 mM GdCl3 for 1.5 h. Cells were double stained with anti-
FLAG antibody (green) and lysotracker (red). The co-localization of FLAG-
tagged CLDN-16 and lysotracker appears yellow in the merged image as
indicated by a white arrow. The scale bar represents 10 μm. (For interpretation of
the references to colour in this figure legend, the reader is referred to the web
version of this article.)
Fig. 4. Effect of CaSR agonists on the localization of CLDN-16 in TJs. The cells
expressing the FLAG-tagged CLDN-16 were cultured in the presence or
absence of CaSR agonists including 5 mM CaCl2, 5 mM MgCl2, 0.5 mM
neomycin, and 0.5 mM GdCl3 for 1.5 h. Cells were double stained with anti-
FLAG (green) and anti-ZO-1 antibodies (red). Images taken under a confocal
microscope show the distribution of FLAG-tagged CLDN-16 and ZO-1 near the
apical surface. The co-localization of FLAG-tagged CLDN-16 and ZO-1
appears yellow in the merged images. The scale bar represents 10 μm. (For
interpretation of the references to colour in this figure legend, the reader is
referred to the web version of this article.)
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USA). TER was measured using a Millicell-ERS epithelial volt-ohmmeter
(Millipore, Billerica, MA, USA). TER values (ohms×cm2) were normalized
based on the area of the monolayer and were calculated by subtracting the blank
values from the filter and the bathing medium. The paracellular diffusion of
FITC-dextran (4000 Da) for 1 h from the apical-to-basal compartments was
measured with a Multilabel Counter 1420 ARVOsx. Transepithelial transport of
Mg2+ from the apical-to-basal compartments was measured using xylidyl blue-I
(XB-I) as described previously [17].
2.8. Statistics
Results are presented as means±S.E.M. Differences between groups were
analyzed with a one-way analysis of variance, and corrections for multiple
comparison were made using Tukey's multiple comparison test. Significant
differences were assumed at Pb0.05.3. Results
3.1. Endogenous expression of CaSR in MDCK Tet-OFF cells
We have generated stable cell lines expressing FLAG-tagged
CLDN-16 by using a tetracycline-inducible system [21]. The
clones show strong transgene expression in the absence of
doxycycline. The induction of CLDN-16 expression had no
obvious effect on the endogenous expression of ZO-1, CaSR, or
actin (Fig. 1).
3.2. Effects of CaSR agonists on the phosphorylation
of CLDN-16
The activation of CaSR induces a modulation of cellular
signaling thereby affecting hormone secretion and renal
Fig. 6. Decreases of TER and magnesium transport by CaSR agonists. The cells expressing FLAG-tagged CLDN-16 were cultured on transwell inserts in the presence
(open bars) or absence (closed bars) of doxycycline. TER (A), the flux of FITC-dextran (B), and Mg2+ transport from the apical-to-basal compartments (C) were
measured after treatment with 0.5 mM neomycin or 0.5 mM GdCl3 for 1.5 h. ⁎⁎Pb0.01. NS, not significantly different (PN0.05).
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calcium and magnesium but also to neomycin and gadolinium.
In MDCK cells expressing FLAG-tagged CLDN-16, CaSR
agonists affected neither the endogenous expression of CaSR
and ZO-1 nor the exogenous expression of FLAG-tagged
CLDN-16 (Fig. 2A). We recently reported that CLDN-16 is
phosphorylated at serine residue via a cAMP/PKA-dependent
pathway in the presence of serum [21]. CaSR agonists decreased
the level of phosphorylated CLDN-16 (Fig. 2B). Furthermore,
these agonists decreased the association of CLDN-16with ZO-1.
These findings are similar to the results obtained with a PKA
inhibitor [17]. ZO-1 binds directly to the PDZ-binding motif of
claudins and connects them to the underlying actin cytoskeleton.
By the activation of CaSR, CLDN-16 appears to dissociate from
the TJ complex. The activation reduced production of intra-
cellular cAMPmediated by the inhibition of adenylate cyclase in
the TAL dissected from the outer medulla of the mouse kidney
[24]. We suggest that CaSR agonists decreased PKA activity,
resulting in the decrease in level of phosphorylated CLDN-16.
To test this hypothesis, we checked PKA activity inMDCK cells
expressing FLAG-tagged CLDN-16. Indeed, PKA activity was
significantly decreased by the CaSR agonists (Fig. 3).
3.3. Translocation of CLDN-16 from TJ to lysosome by
CaSR agonists
In unstimulated cells, FLAG-tagged CLDN-16 was distributed
in the TJ concomitant with ZO-1 (Fig. 4). CaSR agonists partially
induced the translocation of CLDN-16 from the TJ to intracellular
compartments. In contrast, the distribution of ZO-1 was not
changed by CaSR agonists. Next, we performed a double
immunofluorescence analysis of CLDN-16 and a lysosomemarker.
In unstimulated cells, FLAG-taggedCLDN-16 did not overlapwith
lysotracker (Fig. 4). Conversely, FLAG-tagged CLDN-16 was co-
localized with lysotracker in the agonist-treated cells (Fig. 5).
3.4. Decrease of TER and Mg2+ transport by CaSR agonists
As shown in Figs. 4 and 5, CaSR agonists caused the
translocation of CLDN-16 from the TJ to lysosome. Weexamined the effect of the agonists on TER, the flux of FITC-
dextran, and the transepithelial transport of Mg2+ from the
apical-to-basal compartments. Removal of doxycycline induced
an increase in the TER and transepithelial transport (Fig. 6A and
C). In contrast, the flux of FITC-dextran from the apical-to-basal
compartments was unchanged by doxycycline (Fig. 6B). CaSR
agonists significantly decreased the TER and transepithelial
Mg2+ transport. In contrast, the flux of FITC-dextran was un-
changed by the agonists. These results suggest that CaSR ago-
nists induced the translocation of CLDN-16 from the TJ to
lysosome, resulting in the loss of function.
3.5. Loss of CaSR-induced inhibitory effect by dibutyryl cAMP
We reported that CLDN-16 is phosphorylated by a cAMP/
PKA-dependent pathway [17]. As shown in Fig. 3, CaSR agonists
decreased PKA activity. Therefore, it is suggested that CaSR
agonists reduces intracellular cAMP content. The reduction in the
phosphorylation of CLDN-16 by neomycin and gadolinium was
recovered by dibutyryl cAMP (DBcAMP), a membrane-perme-
able cAMP analogue (Fig. 7A). Immunofluorescence microscopy
showed that CLDN-16 is distributed in the TJ concomitant with
ZO-1 in the cells treated with DBcAMP and CaSR agonists
(Fig. 7B). Furthermore, the decrease in TER and transepithelial
Mg2+ transport from the apical-to-basal compartments caused by
CaSR agonists was completely reversed by DBcAMP (Fig. 7C
and D). These results suggested that CaSR agonists negatively
regulate the cAMP/PKA-dependent pathway.
4. Discussion
Different claudins can exist within the same junction and
make ion-selective pores. The exogenous expression of a single
claudin influences paracellular permeability. Claudin-4 or -14
expression reduces permeability to sodium in MDCK II cells
[25]. Claudin-8 expression reduces permeability to not only
monovalent alkali metal cations but also H+, NH4+, and
HCO3
−[26,27]. By contrast, claudin-2 or -15 expression
increases the permeability to sodium [25]. These differences
of ionic charge selectivity may be due to the charges on the first
Fig. 7. Loss of CaSR-induced inhibitory effect by dibutyryl cAMP. The cells
expressing the FLAG-tagged CLDN-16 were incubated with CaSR agonists
including 0.5 mM neomycin and 0.5 mM GdCl3 for 1.5 h in the presence and
absence of 0.5 mM DBcAMP. (A) The total cell lysates were immunopreci-
pitated with polyclonal anti-FLAG antibody. Then, the immune pellets were
immunoblotted with anti-phosphoserine (P-Ser) or monoclonal anti-FLAG
antibody. (B) Cells were double stained with anti-FLAG (green) and anti-ZO-1
antibodies (red). The co-localization of FLAG-tagged CLDN-16 and ZO-1
appears yellow in the merged images. The scale bar represents 10 μm. TER (C)
and the transport of Mg2+ from the apical-to-basal compartments (D) were
measured after treatment with 0.5 mM neomycin or 0.5 mM GdCl3 for 1.5 h in
the presence of 0.5 mMDBcAMP. NS, not significantly different (PN0.05). (For
interpretation of the references to colour in this figure legend, the reader is
referred to the web version of this article.)
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there are ten negatively charged amino acids [14]. The abundant
negative charges may recognize divalent cations and CLDN-16
enhances the transport of calcium and magnesium. Some
mutants with negatively charged amino acids in the first extra-
cellular loop, which are observed in FHHNC, lost the tight
junctional localization and the function to transport magnesium
[15,16]. To control permeability to magnesium, the incorpora-
tion of CLDN-16 into the TJ may be a key regulatory step.
Little is known about how the intracellular distribution of
claudins is regulated. Several reports suggest that the function
and/or localization of claudins are regulated by its phosphory-
lation. Mutant WNK4 phosphorylates the cytosolic carboxyl
terminus of claudin-4 and increases permeability to chloride [28].
The localization and the solubility in Triton X-100 of claudin-4
were not affected by mutant WNK4, suggesting that the increase
in permeability to chloride with mutant WNK4 expression was
not caused by the change in the translocation of claudin-4.
Similarly, claudin-7 is a substrate of WNK4 and phosphorylation
of claudin-7 increases its permeability to chloride [29]. The
carboxyl terminus of claudin-3 is phosphorylated by PKA in
ovarian cells [30]. WTand T192A mutant claudin-3 are localized
in the intercellular junction, whereas T192D mutant claudin-3,
mimicking the phosphorylated state, is diffused from the TJ. In
contrast, the phosphorylation of claudin-5 by PKA increases its
localization to the TJ in endothelial cells [31]. Similarly, PKA
phosphorylates CLDN-16 and increases its localization to the TJ
in MDCK cells [17]. WT CLDN-16 treated with a PKA inhibitor
and S217A mutant CLDN-16, a non-phosphorylated form, is
dissociated from the TJ and translocated to lysosome. The effect
of phosphorylation on the intracellular distribution of claudins
may be different in each claudin.
In the isolated perfused cortical TAL, the transport of
magnesium is passive and dependent on the transepithelial
voltage [2,3]. Secretion of magnesium and calcium into the
lumen increases under conditions of a negative transepithelial
dilution potential, whereas reabsorption increases with a positive
transepithelial dilution potential. We recently reported that the
transport of calcium is also regulated by the transepithelial
voltage in the MDCK cells [23]. Interestingly, reabsorption of
calcium was enhanced by the expression of CLDN-16, whereas
secretion was not affected by the expression. We hypothesized
that the high concentration of calcium in the bath solution
inhibited the excretion of calcium via CLDN-16. In the present
study, we found that the activation of CaSR decreases the level of
phosphorylated CLDN-16. Furthermore, the activation de-
creased the association of CLDN-16 with ZO-1 and induced
the translocation of CLDN-16 from the TJ to lysosome, thereby
reducing the transepithelial transport of magnesium. So far,
Müller et al. [32] reported that mutations in CLDN-16 that loss
association with ZO-1 lead to lysosomal mistargeting. There-
fore, it must be necessary that CLDN-16 associates with ZO-1 to
localize at the TJ. At present, we do not know how phos-
phorylation of CLDN-16 may affect its association with ZO-1.
We reported that dephosphorylated CLDN-16 is ubiquitinated
[17]. Ubiquitinated proteins in plasma membrane are internal-
ized from the cell surface and targeted to lysosome [33, 34]. The
289A. Ikari et al. / Biochimica et Biophysica Acta 1778 (2008) 283–290ubiquitinated CLDN-16 might be pulled out of the membrane,
thereby CDLN-16 loses its association with ZO-1.
CaSR is distributed along the nephron from the proximal
tubule to the collecting duct, being particularly abundant in the
basolateral membrane of the TAL. It has been proposed that
CaSR could function as the physiological receptor for calcium
and magnesium. CaSR is a G protein-coupled receptor, and its
activation leads to two cell signaling pathways [20]. Coupling to
a Gq/11 protein activates phospholipase C, resulting in an
elevation of the intracellular free Ca2+ concentration and the
activation of protein kinase C. The activation of CaSR leads to a
reduction in the intracellular cAMP content. This might occur
via coupling to a pertussis toxin-sensitive Gi protein, which
inhibits adenylate cyclase, or via an indirect mechanism involv-
ing arachidonic acid metabolites. At present, we do not know
what molecule is involved in the activation of adenylate cyclase,
but our recent findings showed that serum factors influence the
phosphorylation of CLDN-16. Furthermore, 2′,5′-dideoxy
adenosine, an adenylate inhibitor, decreased the phosphoryla-
tion of CLDN-16, indicating that CLDN-16 is phosphorylated
by serum factors via the activation of adenylate cyclase [21].
Interestingly, the activation of CaSR induces a reduction in PKA
activity and phosphorylated CLDN-16. DBcAMP abolished the
translocation of CLDN-16 into lysosome and the reduction in the
transepithelial transport of magnesium caused by CaSR
agonists. We suggest that the activation of CaSR decreases
renal magnesium reabsorption in two ways: (1) via a decrease in
the lumen's positive potential [35] and (2) via the internalization
of CLDN-16 from the TJ as shown in the present studies. The
CLDN-16 expression affects permeability to sodium in MDCK
cells [17] and LLC-PK1 cells [15]. Therefore, CLDN-16 might
be also involved in the regulation of the transepithelial voltage.
In conclusion, we found that the phosphorylation and
distribution of CLDN-16 in the TJ are negatively regulated by
CaSR agonists. Elevated concentrations of divalent cations in
the TAL caused the translocation of CLDN-16 from the TJ to
lysosome, resulting in a reduction in the amount of magnesium
reabsorption. This regulatory mechanism might prevent excess
reabsorption of divalent cations and back-flow from the
peritubular space to tubule lumen.
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